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Formation of the apical surface and lumen is
a fundamental, yet poorly understood, step in
epithelial organ development. We show that
PTEN localizes to the apical plasma membrane
during epithelial morphogenesis to mediate
the enrichment of PtdIns(4,5)P2 at this domain
during cyst development in three-dimensional
culture. Ectopic PtdIns(4,5)P2 at the basolateral
surface causes apical proteins to relocalize to
the basolateral surface. Annexin 2 (Anx2) binds
PtdIns(4,5)P2 and is recruited to the apical sur-
face. Anx2 binds Cdc42, recruiting it to the
apical surface. Cdc42 recruits aPKC to the
apical surface. Loss of function of PTEN, Anx2,
Cdc42, or aPKC prevents normal development
of the apical surface and lumen. We conclude
that the mechanism of PTEN, PtdIns(4,5)P2,
Anx2, Cdc42, and aPKC controls apical plasma
membrane and lumen formation.
INTRODUCTION
Most organs consist of epithelial tubes (Lubarsky and
Krasnow, 2003). Despite diversity of developmental
mechanism, tubular organs and related structures, such
as alveoli and cysts, share a common organization, with
the apical (AP) surface lining the central lumen and a baso-
lateral (BL) surface attached to adjoining cells and extra-
cellular matrix (ECM). A key gap in our knowledge of
how cells assemble into tubules is how the AP surface
and lumen are formed.
Culture systems that recapitulate tube morphogenesis
have been useful in understanding the mechanism of tu-
bulogenesis. The three-dimensional (3D) Madin-Darby ca-
nine kidney (MDCK) cell system is an excellent model of
epithelial morphogenesis in vitro (Debnath and Brugge,
2005; Lubarsky and Krasnow, 2003; O’Brien et al.,C2002). MDCK cells embedded in a gel of ECM form cysts,
spherical epithelial monolayers enclosing a central lumen
(Montesano et al., 1991). Results from MDCK and other
systems have led to a general model for tube morphogen-
esis (Lubarsky and Krasnow, 2003; O’Brien et al., 2002). In
this model, the cell interprets an extracellular cue from the
ECM and transduces it into a signal to generate the axis of
polarity. Following this initial event, the most crucial step
is the formation of the central lumen and AP plasma
membrane (PM).
Cdc42 plays a central role in polarization from yeast to
mammals. In metazoa, one target of Cdc42 is Par6, part
of the Par3/Par6/aPKC complex, a master regulator of po-
larity. Cdc42 is associated with formation of tight junctions
(TJs) and the regulation of traffic to the PM (Kroschewski
et al., 1999; Musch et al., 2001). However, activation of
Rac1, but not Cdc42, is needed for epithelial TJ formation
(Mertens et al., 2005). Despite this controversy, Cdc42 is
activated upon cell-cell contact, suggesting a role for
this protein during epithelial morphogenesis (Kawakatsu
et al., 2002; Kazmierczak et al., 2004). Interestingly,
FDG1, a guanine nucleotide exchange factor (GEF) that
regulates Cdc42 activity, is needed for lumen formation
in vivo (Suzuki et al., 2001).
Here, we elucidate a molecular mechanism central to
the formation of the AP PM and lumen during morphogen-
esis in the 3D MDCK system.
RESULTS
PtdIns(4,5)P2 and PTEN Are at the AP PM
To determine the localization of PtdIns(4,5)P2 in MDCK
cysts, we stably expressed the pleckstrin homology (PH)
domain of phospholipase Cd1, a high-affinity marker for
PtdIns(4,5)P2 (Rescher et al., 2004), fused to GFP (PHD-
GFP). PHD-GFP was distributed mainly to the AP PM of
MDCK cysts, where it largely colocalized with the AP
marker gp135/podocalyxin (Figure 1A, arrowheads);
a smaller degree was found in the BL PM, with a distribu-
tion similar to that of actin (see Figure S1A in the Supple-
mental Data available with this article online). Usingell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 383
Figure 1. PtdIns(4,5)P2 and PTEN Localize to the AP PM in Cysts
(A) PtdIns(4,5)P2 is enriched in the AP PM. MDCK PHD-GFP cysts were stained for nuclei (blue) and gp135 (red, top right, merged with DIC). In all
micrographs, single confocal sections through the middle of cysts are shown and nuclei are stained blue unless otherwise indicated. Bottom right
panel shows a magnification of the indicated region of the merged panel (bottom left). Arrowhead indicates the colocalization of PHD-GFP and
gp135 at the AP PM.
(B) PTEN localizes to the AP PM in T84 human colon cysts. Endogenous PTEN could not be localized in MDCK cysts but could be localized in T84
cysts. T84 human colon cells were allowed to form cysts for 8 days; stained for PTEN (green), actin (red), and nuclei; and visualized. Arrowheads in-
dicate PTEN at the AP PM.
(C) GFP-PTEN localizes to the AP PM. MDCK GFP-PTEN cells form cysts at 1, 2, 3, and 4 days. Cells were stained for ZO-1 (red). Arrowheads indicate
GFP-PTEN at the AP PM.
(D) PtdIns(4,5)P2 segregates from PtdIns(3,4,5)P3 during cystogenesis. MDCK PHD-GFP (top) and PH-Akt-GFP (middle, merged with DIC in bottom
row) were plated to form cysts for 4 days. Live cells were analyzed by confocal microscopy at 1, 2, 3, or 4 days. In this and all other micrographs, ‘‘L’’
indicates lumen.
Scale bars are 5 mm.PH-Akt-GFP, a probe for products of PI3K (PtdIns[3,4]P2
and PtdIns[3,4,5]P3; we refer to both collectively as
PtdIns[3,4,5]P3), we found PtdIns(3,4,5)P3 highly enriched384 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.at the BL PM and absent from the AP PM of MDCK cysts in
Matrigel (Figure S1B), confirming previous data in collagen
(Yu et al., 2003).
We analyzed PH-Akt-red and PHD-GFP localization
during cystogenesis. At 16 hr when cysts still lacked lu-
mens, PtdIns(3,4,5)P3 and PtdIns(4,5)P2 were colocalized
to cell-cell and cell-ECM contacts (Figure 1D, left). As
soon as lumens started to form (24–60 hr) and in mature
cysts (72 hr), PtdIns(4,5)P2 became confined mainly to
the AP PM, delimiting the newly formed lumen, whereas
PtdIns(3,4,5)P3 remained associated with cell-cell con-
tacts (Figure 1D, arrowheads, lumen). By contrast,
PtdIns(3,4,5)P3 became exclusively BL (Figure 1D, right
column). These data suggest that segregation of
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 to distinct PM domains
may be important in AP PM and lumen formation.
Next, we investigated the mechanism of enrichment of
PtdIns(4,5)P2 and depletion of PtdIns(3,4,5)P3 in the AP
PM. Phosphatase and tensin homolog on chromosome
10 (PTEN) is a lipid phosphatase whose substrates are
PtdIns(3,4,5)P3 and, to a lesser extent, PtdIns(3,4,)P2.
PTEN thus antagonizes PI3K and increases the level of
PtdIns(4,5)P2 by convertingPtdIns(3,4,5)P3 toPtdIns(4,5)P2
(Maehama and Dixon, 1998). We determined the location
of PTEN using MDCK cells expressing GFP-PTEN, which
localizes similarly to endogenous PTEN (Lacalle et al.,
2004). Initially, most GFP-PTEN was in the cytoplasm,
although a small fraction was in the AP region surrounded
by TJs (Figure 1C, day 1, arrowheads). At later stages (days
2–4), GFP-PTEN was mainly in the AP PM, delimiting the
lumen (Figure 1C). GFP-PTEN also associated with cell-
cell junctions overlapping extensively with PtdIns(4,5)P2
(Figure 1C). We found the same localization of endogenous
PTEN in human colon T84 cells (Figure 1B). Thus, PTEN
is highly enriched in the AP PM, suggesting involvement
in depletion of AP PtdIns(3,4,5)P3 and/or enrichment of
AP PtdIns(4,5)P2.
Loss of PTEN Function Inhibits Lumen Formation
To test whether PTEN is needed to form the AP PM and
lumen, we depleted PTEN using siRNAs. Endogenous
PTEN was reduced to 20%–36% of control using two dif-
ferent siRNA heteroduplexes, PTEN-1 and PTEN-2 (Fig-
ure 2A). When siRNA-transfected cells were plated to
form cysts, most control cells formed normal lumens
(91%) (Figure 2B); MDCK cysts with reduced PTEN
formed cysts of similar size, but only 34% of them had nor-
mal lumens (with PTEN-2 siRNA; 36% with PTEN-1
siRNA). Instead, most cysts with reduced PTEN had mul-
tiple small lumens, though the BL marker b-catenin was lo-
calized normally (Figure 2B, left; quantization in Figure 2C).
Also, F-actin was greatly reduced in PTEN-depleted cysts
(Figure 2B, right). To confirm the role of PTEN, we used
bpV(pic), an inhibitor of PTEN (Schmid et al., 2004). We
observed a dose-dependent inhibition of lumen formation
by bpV(pic) (Figure 2D). Then, we analyzed the effect of
PTEN inhibition on the distribution of PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 during cystogenesis. Whereas in control
cells PtdIns(4,5)P2 segregated from PtdIns(3,4,5)P3 in
the AP PM, in bpV(pic)-treated cells both PtdIns remained
homogenously distributed in the PM, resulting in cystsCwith no central lumen (Figure 2E, arrows indicate
PtdIns(4,5)P2 and PtdIns(3,4,5)P3; arrowheads indicate
TJs). Thus, PTEN is required for enrichment of
PtdIns(4,5)P2 at the AP PM and concomitant removal of
PtdIns(3,4,5)P3 from this domain. PTEN is also needed
for AP PM and lumen formation.
Exogenous PtdIns(4,5)P2 Targets AP Proteins
to the BL Domain
Our results suggested that enrichment of PtdIns(4,5)P2 at
the AP pole initiates formation of the AP PM and lumen. To
test this, we delivered exogenous PtdIns(4,5)P2 to the BL
PM of mature cysts. A similar strategy has been used to
show the effect of exogenous PtdIns(3,4,5)p3 on neutro-
phil polarity (Weiner et al., 2002) and the role of
PtdIns(3,4,5)p3 in expanding the BL surface of MDCK cells
(Gassama-Diagne et al., 2006). Exogenous PtdIns(4,5)P2
induced dramatic shrinkage of the lumen and redistribu-
tion of PHD-GFP from the AP to the BL surface, often in
a patchy distribution (Figure 3A). We also saw relocaliza-
tion of the AP markers gp135 and ezrin, and the (TJ) com-
ponent ZO-1, from the AP to the BL region over 30 min
(Figure 3B and Figure S2A; arrows indicate ZO-1, gp135,
and ezrin localization). Movement seems to occur initially
by extension of the AP surface and projections of the lu-
men out to the cyst periphery, followed by collapse of
the lumen. The area occupied by lateral markers shrank,
with p58 and PtdIns(3,4,5)p3 ending up in small puncta
at the periphery of the cysts at 30 min and eventually
disappearing from the basal region (Figure 3C and
Figure S2B, arrowheads). This phenotype was not caused
by the mere loss of polarity because depolarization in-
duced by calcium depletion did not alter the localization
of AP markers (Figure S2C, arrowheads).
We conclude that ectopic insertion of exogenous
PtdIns(4,5)P2 into the BL PM is sufficient to relocalize
AP and TJ components to the periphery of the cyst,
substantiating a key role for this lipid in constructing the
AP PM.
Annexin 2 Distributes to the AP PM in MDCK Cysts
Annexin 2 (Anx2) is targeted to the PM of epithelial cells by
binding to PtdIns(4,5)P2 (Rescher et al., 2004). To localize
Anx2 in cysts, we stably expressed Anx2-GFP, which was
previously described to behave similarly to the endoge-
nous protein (Merrifield et al., 2001). Anx2-GFP was de-
tected mainly in the AP PM of cells in cysts outlining the
lumen, with a very minor amount at the BL PM (Figure 4A).
Anx2 overlapped extensively with actin (Figure 4A, arrow),
suggesting association of Anx2 with the AP actin cytoskel-
eton. We next analyzed the localization of Anx2-GFP
during cystogenesis. The pattern of localization for
Anx2-GFP was identical to that observed for PtdIns(4,5)P2
(Figure S3A). Therefore, the similar distributions of
PtdIns(4,5)P2 and Anx2 during cyst formation suggests
that Anx2 and PtdIns(4,5)P2 might be involved in forming
the cortical actin cytoskeleton and AP domain.ell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 385
Figure 2. Disruption of PTEN with siRNA or a Specific Inhibitor Blocks Central Lumen Formation
(A) Downregulation of PTEN by siRNA. Total lysates of MDCK cells that had been transfected with siRNAs PTEN-1 and PTEN-2 or with control siRNA
and allowed to form cysts for 72 hr were western blotted for PTEN and GAPDH.
(B) Effect of siRNA PTEN-2 on lumen formation. Cells were transfected with PTEN-2 (bottom) or control (top) siRNA and plated to form cysts for 72 hr.
Cells were stained to detect gp135 (red), b-catenin (green), nuclei (left), and actin (red, right, merged with DIC).
(C) Quantitation of cysts with normal lumens in cells transfected with control siRNA or specific siRNA PTEN-1 or PTEN-2. Values are mean ± SD from
four different experiments. n = 100 cysts/experiment. *p < 0.001.
(D) The PTEN inhibitor bpV(pic) disrupts lumen formation in a dose-dependent manner. MDCK cells forming cysts for 48 hr were treated with indicated
concentrations of bpV(pic). After 48 hr, cells were stained to detect gp135 (red), b-catenin (green), and nuclei (blue) (left). Right panel is quantitation of
cysts with normal lumens in cells treated with 0 (control), 0.1, 1, or 10 mM bpV(pic). The values shown are mean ± SD from three different experiments.
n = 100/experiment. *p < 0.005; **p < 0.001.
(E) BpV(pic) inhibits segregation of phosphoinositides. PHD-GFP (right) or PH-Akt-GFP (left) cells formed cysts for 4 days. The cells were stained to
detect ZO-1 (red), nuclei (left), and gp135 (red, right, merged with DIC).
Scale bars are 5 mm.386 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.
Figure 3. Exogenous PtdIns(4,5)P2 Relocalizes AP and TJ Proteins to the BL PM
MDCK PHD-GFP cells forming cysts for 2 days were incubated with histone (control) or PtdIns(4,5)P2-histone complexes (+PtdIns[4,5]P2) for up to 30
min, fixed, and visualized.
(A) Exogenous PtdIns(4,5)P2 relocalizes PHD-GFP from AP to the basal PM. Arrowheads indicate PHD-GFP enrichment at the AP (control) or basal
PM (+PtdIns[4,5]P2). Scale bar is 10 mm.
(B) Exogenous PtdIns(4,5)P2 relocalizes gp135, actin, and ZO-1 from the AP to the basal PM. Top half of figure was treated with PtdIns(4,5)P2 for
indicated time, while bottom half was control. Samples were stained for actin (red), ZO-1 (green), and nuclei in top rows; and gp135 (red) merged
with DIC in bottom rows. Arrows indicate AP markers and ZO-1. Scale bar is 5 mm.
(C) Exogenous PtdIns(4,5)P2 disrupts lateral PM. The samples were stained for actin (red), p58 (green), and nuclei (left), or for DIC (right). Arrowheads
indicate p58 localization. Scale bar is 5 mm.Loss of Anx2 Inhibits Lumen Formation
To determine whether Anx2 is required for the formation of
the central lumen, we used siRNAs. By using two different
siRNA heteroduplexes, we reduced endogenous Anx2
levels by more than 90% (Figure 4B). As shown before,
the downregulation of Anx2 in MDCK cells induced a dras-
tic concomitant reduction of the Anx2 light chain, p11 (Pui-
sieux et al., 1996). We analyzed the effect of depletion of
Anx2 on cystogenesis. Cells were transfected with Anx2
siRNAs and plated to form cysts. Whereas 84% of control
cysts had normal lumens (Figure 4C), MDCK cysts with
reduced Anx2 formed cysts of similar size, but only 47%
had normal lumens. Most cysts with depleted Anx2 had
multiple small lumens with reduced actin (Figure 4C,
Figure S3B, and quantitation in Figure 4D).
We confirmed the requirement of Anx2 in formation of
the central lumen by using a dominant-negative (DN)Anx2, Anx2CM (Merrifield et al., 2001). Expression of
GFP-Anx2CM during cystogenesis inhibited formation of
the central lumen (Figures S3C and S3D). Furthermore,
when the lumens of the cysts were formed from a mixture
of cells with high and low levels of GFP-Anx2CM, the cor-
tical actin cytoskeleton was formed only in the cells with
low levels of GFP-Anx2CM (Figure 4E). Also, ezrin and ac-
tin underlined the AP surface only of cells with low or no
GFP-Anx2CM, whereas they were absent in the presence
of GFP-Anx2CM (Figure 4E, arrowheads).
Next, we assessed the effects of delivering exogenous
PtdIns(4,5)P2 to the BL PM on Anx2 localization. Exoge-
nous PtdIns(4,5)P2 relocalized Anx2 from the AP to the
BL PM (Figure S3E). Finally, we characterized the effect
of reducing PTEN on localization of Anx2. Reduction of
PTEN inhibited the accumulation of Anx2-GFP at the AP
domain, rendering this protein homogenously distributedCell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 387
Figure 4. Anx2 Localizes to the AP PM and Is Needed for Lumen Formation
(A) MDCK Anx2-GFP cells were grown for 5 days to form mature cysts and were stained for actin (red) and nuclei (blue). Actin and DIC are shown (top
right). Bottom right panel shows a magnification of the region indicated with a white square in the merged panel (bottom left). Arrow indicates coloc-
alization of Anx2-GFP and actin at the AP PM. Scale bar is 5 mm.
(B) Downregulation of endogenous Anx2 and p11 by siRNA to Anx2. Total cell lysates of cysts (48 or 72 hr) treated with siRNAs Anx2-1 and Anx2-2
against canine Anx2, or control siRNA, were analyzed by WB for Anx2, p11, and caveolin-1 as a control.
(C) Effect of siRNA Anx2-2 in lumen formation. MDCK cells were transfected with Anx2-2 (bottom), or control (top) siRNAs and were plated to form
cysts for 48 hr. Cells were stained for gp135 (red), ZO-1 (green), and nuclei. Arrowheads indicate ZO-1. Scale bar is 5 mm.
(D) Quantitation of cysts with normal lumens in cells transfected with scramble (control) siRNA or siRNA Anx2-1 or Anx2-2. Values are mean ±SD from
four different experiments. n = 100/experiment. *p < 0.001.
(E) Anx2CM disrupts the cortical actin cytoskeleton. Cells were infected with a tet-off regulated adenovirus encoding GFP-Anx2CM and were incu-
bated with a low level of dox (1 ng/ml) (GFP-Anx2CM). After 48 hr, cells were fixed, stained for actin (blue) and ezrin (red), and analyzed by confocal
microscopy. Arrowheads indicate disruption of actin cytoskeleton in Anx2-GFP cell. Scale bar is 10 mm.
(F) Downregulation of PTEN by siRNA inhibits AP accumulation of Anx2. Cells expressing Anx2-GFP were transfected with siRNAs to PTEN or control
siRNA cysts formed for 48 hr, fixed, and stained for gp135 (red) and nuclei (blue). Scale bar is 5 mm.in the PM (Figure 4F). These results confirm that Anx2 in
combination with PtdIns(4,5)P2 is required for the forma-
tion of the cortical actin cytoskeleton, AP PM, and lumen.
Anx2 Associates with Cdc42 at the AP PM
PtdIns(4,5)P2 leads to recruitment and activation of Cdc42
in Xenopus egg extracts (Ho et al., 2004). We hypothe-
sized that Cdc42 might be directly involved in AP PM
and lumen formation.
To determine the localization of Cdc42, we stably ex-
pressed Rac1-GFP and Cdc42-GFP, which behave like
the endogenous proteins in MDCK cells (Ehrlich et al.,388 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.2002). The expression of endogenous Rac1 and Cdc42
was reduced to compensate for expression of Rac1-
GFP and Cdc42-GFP, respectively, in these stable lines
(Figure 5A). Rac1-GFP was mostly localized to the cell-
cell junctions at the BL PM (data not shown). However,
the localization of Cdc42-GFP was enriched at the AP
PM, colocalizing extensively with actin (Figure 5B, arrow-
heads). To visualize active Cdc42, we used CBD-GFP,
which detects activated Cdc42 (Nalbant et al., 2004).
CBD binds specifically to Cdc42-GTP via the CRIB do-
main of WASp (aa 201–321). At day 1 (Figure 5C, left),
Rac1, Cdc42, and CBD-GFP localized to cell-cell and
cell-ECM contacts (Figure 5C; arrows indicate Cdc42 and
Rac1 at cell-cell contacts). However, as cysts started to
form lumens and thereafter (days 2–5), the majority of
CBD-GFP relocalized to the AP PM together with
Cdc42, delimiting the newly formed lumen (Figure 5C,
days 2 and 5, middle and right, arrowheads indicate
CBD-GFP and Cdc42 at the lumen). By contrast, Rac1 re-
mained mostly at cell-cell contacts throughout cystogen-
esis. To confirm activation of Cdc42 during lumen forma-
tion, we pulled down active Rac1 and Cdc42 using the
p21-binding domain of PAK1 fused to GST (Benard
et al., 1999). Cdc42-GTP increased significantly during
cystogenesis (Figure S4A).
Phosphoinositides recruit Rho family GTPases to the
PM through PH domains of GEFs (Ferguson et al., 1995).
However, the PH domains of GEFs bind phospholipids
with low affinity and little specificity, implying that these in-
teractions are insufficient to specify PM localization of Rho
proteins (Snyder et al., 2001). We hypothesized that the
high-affinity PtdIns(4,5)P2-binding protein Anx2 mediates
the interaction between PtdIns(4,5)P2 and Cdc42. Anx2
binds to the active form of another Rho family GTPase,
Rac1 (Hansen et al., 2002). Endogenous Cdc42 coprecipi-
tated with Anx2-GFP (Figure 5D, immunoprecipitation [IP]
blot). This interaction was increased in the presence of
GTPgS (Figure 5D). Anx2-GFP also interacted with endog-
enous Anx2 (data not shown) and P11 (Figure 5D, bottom),
indicating that this protein forms normal heterotetramers.
The association of Anx2-GFP with p11, the ligand of
Anx2, was stronger in the presence of GDP, while the co-
precipitation of Cdc42 was reduced, suggesting competi-
tion of active Cdc42 and p11 for Anx2 binding (Figure 5D,
IP blot). As expected, endogenous Anx2 coprecipitated
with Cdc42-GFP and this interaction was stabilized in the
presence of GTPgS (Figure 5E). We also observed an inter-
action between Cdc42-GFP and IQGAP1 as described
(Hart et al., 1996), which was stabilized by GTPgS, indicat-
ing normal behavior of Cdc42-GFP (Figure 5E, bottom).
To confirm the interaction of Cdc42 and Anx2 in vivo, we
expressed transdominant Anx2, Anx2XM. Anx2XM is
a chimera of the NH2 terminus (residues 1–18) of Anx2
fused to the NH2 terminus of p11. Expression of Anx2XM
leads to the formation of cytosolic aggregates containing
endogenous Anx2, p11, and the chimera (Harder and
Gerke, 1993). Expression of Anx2XM aggregated Anx2-
GFP in the cytosol (Figure 5G, arrowheads), disrupted par-
tially the AP actin cytoskeleton (Figure 5G, arrow), and, im-
portantly, aggregated Cdc42-GFP in the cytosol
(Figure 5H, arrowheads). By contrast, Anx2XM did not
change the localization of Rac1-GFP (Figure S4B), or the
BL protein b-catenin (Figure S4C). Thus, Anx2 binds to
Cdc42 in vivo and the presence of Anx2 in the AP PM is
required for the proper AP localization of Cdc42.
Depletion of Cdc42 Inhibits Formation of the Central
Lumen
We reduced the level of Cdc42 by 90% using siRNA
(Figure 6A). Whereas most of the control cysts formed nor-mal lumens (75%), only 17% showed normal lumen for-
mation in cysts with reduced Cdc42 (Figure 6B, quantita-
tion in Figure 6C, and 3D views of cysts in Movies S1 and
S2). More than 80% of cysts with reduced Cdc42 had mul-
tiple small lumens with decreased F-actin and the cortical
actin-associated protein (Figure 6B), resembling the phe-
notype observed with reduction of PTEN or Anx2 (Figures
2 and 4). b-catenin remained at cell-cell contacts, indicat-
ing that the BL surface is relatively normal (Figure 6B, left).
Thus, functional disruption of Cdc42 induces accumula-
tion of AP markers in lumens between cells and probably
in large intracellular vesicles (Figure 6B, left). By contrast,
reduction of Cdc42 did not affect polarity of MDCK cells in
2D monolayers (Figure S5A).
To understand the role of Cdc42 in the formation of the
AP PM and the lumen, we analyzed the effect of reducing
Cdc42 on the localization of the AP marker gp135 during
cystogenesis. Gp135 localized initially to external PM
(Figure 6D, left), confirming the described distribution of
this protein to free surfaces in nonpolarized epithelial cells
(Meder et al., 2005). Then, gp135 relocalized to internal
vesicles, presumably by endocytosis. Cdc42 disruption
did not affect this relocalization (Figure 6D, 16 hr panels,
arrows). However, whereas in control cells these internal
vesicles fused with the PM to form lumens between cells,
in the cysts with reduced Cdc42, gp135 accumulated in
intracellular vesicles that did not fuse with the PM
(Figure 6D, 24 hr panels, arrowheads). Because we re-
duced but did not eliminate Cdc42, eventually some of
these vesicles fused with the PM, generating mature cysts
with intracellular and small intercellular lumens (Figure 6D,
right, arrows indicate intercellular and arrowheads indi-
cate intracellular lumens). Another possibility for formation
of the central lumen is that a single lumen forms by coales-
cence of multiple intercellular lumens. However, we ob-
served that most cysts with single lumens formed without
a preceding multilumenal intermediate (Figure 6D, top,
quantitation in Figure S5B). TJs were apparently unaf-
fected, as indicated by the staining for ZO-1 (Figure S5C,
arrowheads).
Exogenous PtdIns(4,5)P2 Targets Activated Cdc42
to the BL PM and Reduces the Central Lumen
Our data suggest a model for lumen formation that is initi-
ated by the PTEN-dependent enrichment of PtdIns(4,5)P2
at the AP pole of MDCK cells. PtdIns(4,5)P2 recruits Anx2,
which in turn recruits Cdc42. Cdc42 is essential for forma-
tion of the AP PM and lumen.
To test this, we analyzed the localization and activity of
Cdc42 in cells depleted of PTEN or Anx2. We observed
a drastic reduction of Cdc42 activity in the cysts with re-
duced levels of PTEN or Anx2, as measured by GST-
Pak1-CRIB pull-down (Figure 6E). Activated Cdc42 was
reduced in cysts with reduced Cdc42 or in cysts express-
ing the DN form of Cdc42, Cdc42-N17 (Figure 6E). Despite
the effect on the localization of actin, gp135, ezrin, and
ZO-1 upon depletion of Cdc42, Anx2, or PTEN, we did
not see alterations in total protein levels of these markersCell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 389
Figure 5. Anx2 Binds to Cdc42 at the AP PM
(A) Western blot of stable expression of Rac1-GFP or Cdc42-GFP. Extracts from MDCK Cdc42-GFP, Rac1-GFP, or control cells were immunoblotted
with anti-Rac1 (left) and anti-Cdc42 (right) to detect endogenous and transfected proteins.
(B) Cdc42-GFP distribution in mature cysts. Cdc42-GFP cells were grown for 5 days and stained for nuclei (blue) and actin (red). Bottom right panel
shows the magnification of the indicated region of the merged panel (bottom left). Arrowheads indicate colocalization of Cdc42-GFP and actin at the
AP PM. Scale bar is 10 mm in the top right panel and 2 mm in the bottom right panel.
(C) Distribution of CBD-GFP, Cdc42-GFP, and Rac1-GFP during cystogenesis. MDCK CBD-GFP (top), Cdc42-GFP (middle) or Rac1-GFP (bottom)
cells were grown for 1, 2, or 5 days and visualized. Arrows indicate fluorescent proteins at cell-cell or cell-ECM junctions. Arrowheads indicate the
localization of CBD-GFP and Cdc42-GFP at the AP surface. Scale bars are 5 mm or 10 mm as indicated.390 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.
(Figure S6A). Confirming the biochemical results, we also
observed a relocalization of Cdc42 from the plasma PM to
the cytoplasm upon knockdown of either PTEN or Anx2
(Figures S6B and S6C).
We next assessed the effects of delivering exogenous
PtdIns(4,5)P2 to the BL PM on the localization and activity
of Cdc42. Exogenous PtdIns(4,5)P2 induced the relocali-
zation of Cdc42-GFP (Figure 6F, arrowheads) and CBD-
GFP (Figure S6D) from the AP domain to the cytoplasm
with enrichment at the basal portion of the cyst. Thus, ac-
tivated Cdc42 followed a pattern of redistribution similar
to that observed for PHD-GFP, Anx2, gp135, ezrin, and
ZO-1. The partial translocation of activated Cdc42 to the
basal PM was associated with the formation of a partial
abnormal actin cytoskeleton at the periphery of the cyst
(Figure S6D, arrowheads). In sum, these data show that
PtdIns(4,5)P2-mediated AP enrichment of Anx2 targets
activated Cdc42 to regulate the formation of the AP PM
and lumen during epithelial morphogenesis.
Cdc42 Targets Par6/aPKC to the AP PM to Form
the Lumen
The Rho-GTPase effector protein Par6 links Par3 and
aPKC to activated Cdc42, forming a multimeric polarity-
regulatory complex at the PM of MDCK cells (Joberty
et al., 2000). We addressed the role of the Par3/Par6/
aPKC complex in the formation of the AP PM and lumen
in MDCK cysts. First, we characterized the localization
of members of this complex. Interestingly, whereas
aPKC (Figure 7A, top) and Par6 (data not shown) distrib-
uted along the whole AP PM, Par3 was confined to the
TJs (Figure 7A, bottom). This differential distribution of
Par3 and Par6/aPKC was previously found in Drosophila
(Harris and Peifer, 2005) and suggests that Cdc42/Par6/
aPKC could have a specific role in the morphogenesis of
the AP PM independent of Par3. Since activated Cdc42
is enriched at the AP PM, these data also suggest that
the activity of Par6/aPKC at the AP PM is dependent on
Cdc42.
To test whether the localization of aPKC at the AP PM
depends on Cdc42, we characterized the distribution of
aPKC in cells depleted of Cdc42. In cysts depleted of
Cdc42, aPKC localized intracellularly and partially colo-
calized with Anx2-GFP on intracellular lumens (Figure 7C,
arrowhead). The localization of aPKC to the AP PM also
depends on PTEN and Anx2, because the reduction ofthese proteins caused intracellular accumulation of
aPKC (Figures S7A and S7B). Interestingly, we also found
a partial intracellular accumulation of Anx2 in the cells with
reduced Cdc42 (Figure 7C). By contrast, PtdIns(4,5)p2 re-
mained associated with the plasma PM in the cells with re-
duced Cdc42 (data not shown). These data suggest that,
whereas the enrichment of PtdIns(4,5)p2 at the AP PM
might control this whole pathway, there is a potential pos-
itive feedback loop between Cdc42 and Anx2 to promote
the localization of AP proteins at the lumen of mature
cysts.
To address the role of Par6/aPKC in AP PM and lumen
formation, we used a myristoylated pseudosubstrate of
aPKC-z (aPKC-PS) that specifically inhibits all aPKCs
(Nunbhakdi-Craig et al., 2002). Treatment with aPKC-PS
inhibited phosphorylation of aPKC, as well as formation
of the AP PM and central lumen in a dose-dependent man-
ner (Figures 7B, 7D, and 7E). In contrast, we saw a normal
distribution of ZO-1, as previously described in MDCK
monolayers (Fan et al., 2004). Finally, we found that exog-
enous PtdIns(4,5)P2 relocalized aPKC from the AP to the
basal PM (Figure S7C, arrowheads). Thus, aPKC followed
a pattern of redistribution similar to that of PHD-GFP,
Anx2, activated Cdc42, gp135, ezrin, and ZO-1.
In sum, these data show that PTEN, PtdIns(4,5)P2,
Anx2, and activated Cdc42 are required for the targeting
and localization of Par6/aPKC to the AP domain to regu-
late the formation of the AP PM and lumen during epithelial
morphogenesis.
DISCUSSION
Formation of the AP surface and lumen is a central prob-
lem in understanding how epithelial tissues arrange them-
selves into tubes and other hollow structures, such as
cysts. We have uncovered a molecular mechanism of
AP surface and lumen formation (model in Figure 7F).
PTEN is needed for segregation of PtdIns(4,5)p2 to the
AP PM and PtdIns(3,4,5)p3 to the BL PM. AP PtdIns(4,5)p2
recruits Anx2, which in turn recruits Cdc42 to the AP PM,
causing the organization of the sub-AP actin cytoskeleton
and formation of the AP surface and lumen. Cdc42 binds
and localizes the Par6/aPKC complex to the AP PM to
promote establishment of polarity.
PtdIns(4,5)p2 is thus a key determinant of the AP sur-
face. Similarly, PtdIns(3,4,5)p3 is a key determinant of(D) Anx2-GFP interacts with endogenous Cdc42 in a GTP-dependent manner. MDCK Anx2-GFP or control cells in mature cysts were lysed, and ex-
tracts were loaded with GDP or GTPgS. Extracts were immunoprecipitated with antibody against GFP and immunoblotted to analyze Cdc42 and p11.
Three percent of input or 30% of immunoprecipitated material was loaded on the gel. A band corresponding to the light chain (LC) of IgG was detected
with the anti-Cdc42 antibodies and served as a loading control.
(E) Cdc42-GFP interacts with endogenous Anx2 in a GTP-dependent manner. Cdc42-GFP or control cells in mature cysts were lysed, and the extracts
were loaded with GDP or GTPgS. Extracts were immunoprecipitated using antibodies against GFP and immunoblotted to analyze Anx2 and IQGAP1.
Three percent of input and 30% of immunoprecipitated material were loaded in the gel.
(F–H) Effect of tet-off inducible adenovirus-mediated expression of Anx2XM on Anx2-GFP or Cdc42-GFP localization in cysts. MDCK Anx2-GFP (G)
or Cdc42-GFP (H) cells forming cysts for 5 days were infected with a tet-off regulated adenovirus encoding Anx2XM and maintained in the presence
(control) or absence (Anx2XM) of 20 ng/ml of dox for 16 hr. Cells were lysed and extracts were analyzed by WB to detect Anx2XM (F). The cysts were
stained for actin (red) and nuclei (blue). Arrowheads indicate aggregates of Anx2-GFP or Cdc42-GFP. Arrows indicate disruption of the AP actin cy-
toskeleton. Scale bar is 10 mm.Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 391
Figure 6. Cdc42 siRNA Inhibits Formation of Central Lumen
(A) Downregulation of Cdc42 by siRNA. Cells were transfected with siRNAs Cdc42-1 and Cdc42-2 against canine Cdc42 or with control siRNA and
allowed to form cysts for 48 or 72 hr, and then total cell lysates were western blotted for Cdc42 and b-tubulin (control).
(B) Effect of Cdc42-1 siRNA on lumen formation. MDCK cells were transfected with Cdc42 siRNA (bottom) or siRNA control (top) and
plated to form cysts for 48 hr. Cells were stained to detect actin (red), ezrin (blue), b-catenin (green, left), and nuclei (right, merged
with DIC).392 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.
the BL surface (Gassama-Diagne et al., 2006). Together,
PtdIns(4,5)p2 and PtdIns(3,4,5)p3 play complementary
roles in epithelial polarity. More generally, phosphoinositi-
des have emerged as general determinants of membrane
identity (Di Paolo and De Camilli, 2006). An advantage of
epithelia is that we can insert exogenous phosphoinositi-
des into limited ectopic locations. These gain-of-function
experiments provide a direct test of the role of the lipid
in specifying domain identity.
To exert its effects, PtdIns(4,5)p2 interacts with Anx2,
which clusters this lipid with high affinity and specificity.
Ectopic PtdIns(4,5)p2 in the BL surface recruits Anx2 to
the BL PM. Although loss of Anx2 by RNAi prevents lumen
formation, RNAi of Anx2 did not produce as strong a phe-
notype as expression of the DN Anx2CM or RNAi of PTEN
or Cdc42. One explanation could be the existence of 20
annexin family members, which might have redundancy
with each other. Indeed, Anx2 knockout (KO) mice are
viable (Ling et al., 2004). Alternatively, even low levels of
Anx2 might suffice to exert its function.
Cdc42 interacts with Anx2 in a GTP-dependent manner.
Cdc42 is activated during cystogenesis. Most activated
Cdc42 relocalizes from cell-cell contacts to the AP pole
as lumens form. RNAi of Cdc42 caused malformation of
the central lumen in cysts but did not affect polarization
of MDCK cells in 2D monolayers. This effect of Cdc42 de-
pletion in cysts highlights the importance of using 3D
models in analysis of lumen formation. Interestingly, we
also saw an intracellular accumulation of Anx2 in the cells
with reduced Cdc42, suggesting a potential positive feed-
back loop whereby Cdc42 and Anx2 each promote the lo-
calization of the other at the lumen of mature cysts. Anx2
might work by recruiting Cdc42 or a GEF for Cdc42, and
this GEF may in turn activate Cdc42 at this location. On
the other hand, active Cdc42 might promote the exocyto-
sis of Anx2 and other AP proteins.
Formation of the AP surface and lumen has been sug-
gested to be mediated by exocytosis of large intracellular
vacuoles, termed vacuolar apical compartment (VAC)
(Vega-Salas et al., 1987). Formation of endothelial lumens
occurs by vacuolar exocytosis (Kamei et al., 2006). Cdc42
is needed for the exocytosis of secretory vesicles from
neuroendocrine cells, apparently via rearrangement of
the actin cytoskeleton, and this may be analogous to thefusion of VACs or smaller vesicles with the AP surface
(Malacombe et al., 2006). We saw accumulation of appar-
ent VACs when Cdc42 was depleted. Similarly, DN Cdc42
blocks capillary lumen formation (Bayless and Davis,
2002). Perhaps during normal MDCK cyst lumen formation
smaller vesicles are rapidly exocytosed to form the lumen.
Inhibition of this by Cdc42 depletion may cause the accu-
mulation of larger, more easily detected VACs. Indeed,
this may be the defect underlying the phenotypes we ob-
served with loss of function of PTEN, Anx2, Cdc42, or
aPKC. Cdc42 is also needed for exit of AP and BL proteins
from the trans-Golgi network (TGN) (Musch et al., 2001),
so Cdc42 may act at multiple levels in the formation of
the AP surface.
Localized active Cdc42 may promote formation of the
AP surface and lumen by additional mechanisms. Active
Cdc42 binds to Par6, a member of the Par3/Par6/aPKC
complex that regulates TJ and polarity formation (Munro,
2006). In Drosophila, Par6/aPKC functions at the AP PM
independently of Par3, which is associated with the junc-
tional complex. Indeed, we have found that Par6/aPKC lo-
calizes at the AP PM of MDCK cysts independently of
Par3, and that the disruption of aPKC function inhibits nor-
mal lumen formation. Mutation of zebrafish aPKCl causes
defects in lumen formation in the intestine (Horne-Badovi-
nac et al., 2001). These data suggest the existence of two
distinct Par complexes for the establishment of epithelial
polarity: a complex of Par6/aPKC localized to the AP PM
and involved in the formation of this domain; and a com-
plex that also includes Par3, localized at the TJs and re-
quired for their formation.
We previously reported that inhibition of Rac1 or b1-
integrin in cysts leads to inversion of polarity orientation
and abnormal organization of laminin (O’Brien et al.,
2001; Yu et al., 2005). Rac1, b1-integrin, and laminin may be
part of a pathway that determines orientation of the axis of
polarity, while PTEN, PtdIns(4,5)p2, Anx2, Cdc42, and
Par6/aPKC are part of a pathway that controls formation
of the AP surface and lumen. The Rac1/b1-integrin/laminin
pathway might be upstream and/or parallel to the PTEN/
PtdIns(4,5)p2/Anx2/Cdc42 pathway, and it determines the
location of the AP surface. Because activation of Rac1 at
the primordial adhesions of epithelial cells controls the
association and activation of the Par3/Par6/aPKC complex(C) Quantitation of cysts with normal lumens in cells transfected with control siRNA (black bars), specific siRNA Cdc42-1 (white bars) or Cdc42-2 (gray
bars). Values shown are mean ± SD from four different experiments. *p < 0.001.
(D) Time course analysis of gp135 localization during lumen formation in control and Cdc42-depleted cells. Cells were transfected with Cdc42 siRNA-1
(bottom) or siRNA control (top) and plated to form cysts for 8, 16, 24, and 48 hr. Cells were stained to detect gp135 (red), b-catenin (green), and nuclei.
Arrows indicate small intracellular vesicles at 16 hr and intercellular lumens at 48 hr. Arrowheads indicate intracellular lumens.
(E) siRNA-mediated reduction of PTEN and Anx2 inhibits activation of Cdc42. Cells were transfected with siRNAs Cdc42-1, Anx2-2, or PTEN-2 or with
control siRNAs; or cells were infected with adenovirus expressing myc-tagged Cdc42-N17. Total cell lysates of cysts at 48 hr were immunoblotted for
Cdc42, Anx2, and PTEN (top left) or for Cdc42 (bottom left). Extracts from these cells were pulled down with PBD-PAK1-GST. Total and GTP-bound
Cdc42 was detected by immunoblotting with specific antibodies, and the ratios of GTP-bound to total protein were quantified. Values shown are
mean ± SD from three different experiments.
(F) Exogenous PtdIns(4,5)P2 delocalizes Cdc42-GFP from the AP PM. Cdc42-GFP cysts at 48 hr were incubated with PtdIns(4,5)P2-histone com-
plexes for 30 min (+PtdIns[4,5]p2) or histone alone (control), fixed, and analyzed by confocal microscopy. Arrowheads indicate Cdc42-GFP enrichment
at the basal PM.
Scale bars are 5 mm.Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 393
Figure 7. Cdc42 Targets aPKC to the AP Plasma PM to Form the Central Lumen
(A) aPKC and Par3 distribute differently in nature cysts. Cysts were stained for aPKCl (top) or Par3 (bottom) (red, left), b-catenin or ZO-1 (green, mid-
dle), and for nuclei (merged with DIC, right). Arrowheads indicate aPKC at the AP PM, and colocalization of Par3 and ZO-1 at TJs.
(B) aPKC-PS disrupts lumen formation. MDCK cysts were treated with aPKC-PS (40 mM) or left untreated (control). Cells were stained to detect gp135
(red), b-catenin (green), and nuclei in left panels; or cells were stained for ZO-1 (red) and b-catenin (green), and the images were merged with DIC in
right panels.
(C) Reduction of Cdc42 induces intracellular accumulation of aPKC and Anx2. Anx2-GFP cells were transfected with Cdc42 or control siRNAs and
plated to form cysts for 48 hr. Cells were stained for aPKC (red), and the images were merged with images of cells stained for Anx2-GFP and nuclei
(bottom right) and for actin (red, bottom left, merged with DIC). Arrowheads indicate aPKC at the AP PM in control cells (left), or to the intracellular
vesicles in Cdc42-depleted cells (right).
(D) The aPKC inhibitor aPKC-PS disrupts lumen formation in a dose-dependent manner. MDCK cysts were treated with indicated concentrations of
aPKC-PS for 48 hr. Cells were then fixed, stained, and quantified for lumen formation. Values shown are mean ± SD from three different experiments.
n = 100/experiment.
(E) aPKC-PS inhibits aPKC phosphorylation in a dose-dependent manner.394 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.
to induce TJ biogenesis and cell polarity (Mertens et al.,
2005), one potential connection between these pathways
might be the targeting of PTEN to the AP domain through
its interaction with TJs. PTEN localizes to the adherens
junctions in fly epithelium through its interaction with Ba-
zooka/Par3 (von Stein et al., 2005). Here, we show that
PTEN is needed for AP PM and lumen formation during
cyst development and that Par3 localizes specifically to
the TJs in MDCK cyst. This observation is consistent with
previous studies showing that the expression of DN Par-3
cells disrupted MDCK cyst morphogenesis, causing the
lack of a central lumen (Hurd et al., 2003).
EXPERIMENTAL PROCEDURES
Reagents
Primary antibodies were mouse (unless otherwise specified) against
the following: b-tubulin (Chemicon); b-catenin (rabbit) and myc
(Sigma); GFP (Roche); anti-Rac1, Cdc42, Anx2, p11, anti-IQGAP1,
ezrin, GAPDH, aPKCl, and caveolin-1 (rabbit) (BD Transduction Lab);
PTEN (Cell Signaling); ASIP/Par3 (rabbit, Zymed); phospho-Thr410-
aPKC (rabbit, Santa Cruz); p58 (gift of K. Matlin); ZO-1 (rat R40.76;
gift from B. Stevenson); and gp135 (gift of George Ojakian). Secondary
antibodies used were highly crossabsorbed anti-mouse Alexa Fluor
546 and anti-rabbit Alexa Fluor 488 (Molecular Probes), as well as
goat anti-rabbit or anti-mouse HRP (Jackson). Actin filaments were
stained with Alexa Fluor 488, 546, or 633 phalloidin (Molecular Probes).
Nuclei were stained with Hoescht (Molecular Probes). aPKC-PS
inhibits aPKC (Biosource).
Cells
MDCK cells were grown as described (O’Brien et al., 2001; Yu et al.,
2005). MDCK stably expressing Cdc42-GFP, Rac1-GFP, Anx2-GFP,
PHD-GFP, and PH-Akt-GFP (construct from T. Balla, NIH), PH-Akt-
red (construct from H. Bourne, UCSF), GFP-PTEN, and CBD-GFP
(from K. Hahn, U. of North Carolina) were made by cotransfection
with blasticidin-resistant gene. After 3 weeks in selective medium,
clones were isolated and analyzed by immunofluorescence (IF) and
western blot (WB).
To prepare cysts in Matrigel, cells were trypsinized to a single cell
suspension of 4 3 104 cells/ml in 2% Matrigel. Cells in Matrigel (250
ml) were plated in 8-well coverglass chambers (Nalge Nunc) covered
with Matrigel. Cells were fed every 2 days and grown for 2–5 days until
cysts with lumen formed.
Adenovirus
Preparation of recombinant adenoviruses encoding Anx2-GFP, GFP-
Anx2CM, and Anx2XM was obtained by subcloning into pADtet,
downstream of tetracycline-responsive elements. Construction of ad-
enoviruses through CRE-lox recombination and viruses were as de-
scribed (Altschuler et al., 1998). For infection, cysts were washed
well with PBS+ and incubated for 10–15 min in trypsin (Ca2+ and
Mg2+) at 37C to disrupt Matrigel. After inhibiting trypsin with medium +
serum, Matrigel-free cysts were infected with the adenovirus follow-
ing the protocol described before for cells in monolayer.
Microscopy
Immunofluorescence of cysts was previously described (O’Brien et al.,
2001; Yu et al., 2005). Cysts were analyzed on a Zeiss 510 LSM. Cystswith actin/gp135 staining at the interior surface and b-catenin facing
the ECM were identified as normal lumens (interior AP pole). Cysts
that had actin/gp135 either absent, in small multiple lumens, or at
the periphery were considered as abnormal lumens. Per condition,
more than 100 cysts/experiment were analyzed, standard deviation
(SD) was calculated, and statistical significance was determined by
paired Student’s t test.
Biochemistry
Preparation of lysates, immunoblotting, and CoIP in cysts was de-
scribed before (O’Brien et al., 2001; Yu et al., 2005); for more informa-
tion, see the Supplemental Data.
GTPase Activation
Cysts (1–4 days old) were lysed in 500 ml of 4C 23 gold lysis buffer
(2% Triton X-100, 40 mM Tris-HCl [pH 7.5], 1000 mM NaCl, 20 mM
MgCl2, 30% glycerol, 1 mM dithiothreitol, and EDTA-free protease in-
hibitors; Roche), then microcentrifuged at 15,000 rpm for 5 min. A 50 ml
sample from the supernatant was set aside for determination of Cdc42
and Rac levels in the total lysate, and GTP loading on Cdc42 and Rac1
was determined with GST-Pak3-CRIB bead pull-down as described
(Hansen and Nelson, 2001).
RNAi
Twenty-five nucleotide siRNA duplexes targeting mRNA sequences of
canine Cdc42, Anx2, and PTEN were purchased from Invitrogen (de-
tails in Supplemental Experimental Procedures). Sequences were sub-
mitted to BLAST search to ensure targeting specificity. The specificity
of PTEN, Cdc42, and Anx2 downregulations was further checked by
WB analysis. MDCK cells plated at low density (3 3 104/cm2) were
transfected with 20 nM solutions of either PTEN, Anx2, or Cdc42 siRNA
duplex, or scrambled siRNA using Lipofectamine 2000 (Invitrogen),
and incubated for 24 hr after transfection in the same plates. Then
the cells were plated to form cysts for 2–5 days as described above
and then prepared for confocal and WB analysis.
PtdIns(4,5)P2 Basal Delivery
Basal delivery of PtdIns(4,5)P2 in cysts in Matrigel was previously de-
scribed (Gassama-Diagne et al., 2006). For more details, see Supple-
mental Experimental Procedures.
Supplemental Data
Supplemental Data include seven figures, Supplemental Experimental
Procedures, and two movies and can be found with this article online at
http://www.cell.com/cgi/content/full/128/2/383/DC1/.
ACKNOWLEDGMENTS
We thank H. Bourne, C.M. Ruiz-Jarabo, M.A. Alonso, and P. Leroy for
comments on the manuscript, and members of the Mostov lab for dis-
cussion. This research was supported by HFSP fellowship LT00426/
2004-C to F.M.-B., the National Kidney Association (W.Y.), and NIH
grants to K.M.
Received: April 12, 2006
Revised: September 7, 2006
Accepted: November 14, 2006
Published: January 25, 2007(F) Model: PtdIns(3,4,5)p3 (red) and PtdIns(4,5)p2 (green) colocalize in unpolarized MDCK cells (yellow). AP recruitment of PTEN induces the accumu-
lation of PtdIns(4,5)p2 at the AP domain. PtdIns(4,5)p2 recruits Anx2, Cdc42, and Par6/aPKC to form the AP PM and lumen.
Scale bars are 5 mm.Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 395
REFERENCES
Altschuler, Y., Barbas, S.M., Terlecky, L.J., Tang, K., Hardy, S., Mos-
tov, K.E., and Schmid, S.L. (1998). Redundant and distinct functions
for dynamin-1 and dynamin-2 isoforms. J. Cell Biol. 143, 1871–1881.
Bayless, K.J., and Davis, G.E. (2002). The Cdc42 and Rac1 GTPases
are required for capillary lumen formation in three-dimensional extra-
cellular matrices. J. Cell Sci. 115, 1123–1136.
Benard, V., Bohl, B.P., and Bokoch, G.M. (1999). Characterization of
rac and cdc42 activation in chemoattractant-stimulated human neu-
trophils using a novel assay for active GTPases. J. Biol. Chem. 274,
13198–13204.
Debnath, J., and Brugge, J.S. (2005). Modelling glandular epithelial
cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675–688.
Di Paolo, G., and De Camilli, P. (2006). Phosphoinositides in cell regu-
lation and membrane dynamics. Nature 443, 651–657.
Ehrlich, J.S., Hansen, M.D., and Nelson, W.J. (2002). Spatio-temporal
regulation of Rac1 localization and lamellipodia dynamics during epi-
thelial cell-cell adhesion. Dev. Cell 3, 259–270.
Fan, S., Hurd, T.W., Liu, C.J., Straight, S.W., Weimbs, T., Hurd, E.A.,
Domino, S.E., and Margolis, B. (2004). Polarity proteins control cilio-
genesis via kinesin motor interactions. Curr. Biol. 14, 1451–1461.
Ferguson, K.M., Lemmon, M.A., Schlessinger, J., and Sigler, P.B.
(1995). Structure of the high affinity complex of inositol trisphosphate
with a phospholipase C pleckstrin homology domain. Cell 83, 1037–
1046.
Gassama-Diagne, A., Yu, W., ter Beest, M., Martin-Belmonte, F., Kier-
bel, A., Engel, J., and Mostov, K. (2006). Phosphatidylinositol-3,4,5-
trisphosphate regulates the formation of the basolateral plasma mem-
brane in epithelial cells. Nat. Cell Biol. 8, 963–970.
Hansen, M.D., and Nelson, W.J. (2001). Serum-activated assembly
and membrane translocation of an endogenous Rac1:effector com-
plex. Curr. Biol. 11, 356–360.
Hansen, M.D., Ehrlich, J.S., and Nelson, W.J. (2002). Molecular mech-
anism for orienting membrane and actin dynamics to nascent cell-cell
contacts in epithelial cells. J. Biol. Chem. 277, 45371–45376.
Harder, T., and Gerke, V. (1993). The subcellular distribution of early
endosomes is affected by the annexin II2p11(2) complex. J. Cell
Biol. 123, 1119–1132.
Harris, T.J., and Peifer, M. (2005). The positioning and segregation of
apical cues during epithelial polarity establishment in Drosophila. J.
Cell Biol. 170, 813–823.
Hart, M.J., Callow, M.G., Souza, B., and Polakis, P. (1996). IQGAP1,
a calmodulin-binding protein with a rasGAP-related domain, is a poten-
tial effector for cdc42Hs. EMBO J. 15, 2997–3005.
Ho, H.Y., Rohatgi, R., Lebensohn, A.M., Le, M., Li, J., Gygi, S.P., and
Kirschner, M.W. (2004). Toca-1 mediates Cdc42-dependent actin nu-
cleation by activating the N-WASP-WIP complex. Cell 118, 203–216.
Horne-Badovinac, S., Lin, D., Waldron, S., Schwarz, M., Mbamalu, G.,
Pawson, T., Jan, Y., Stainier, D.Y., and Abdelilah-Seyfried, S. (2001).
Positional cloning of heart and soul reveals multiple roles for PKC
lambda in zebrafish organogenesis. Curr. Biol. 11, 1492–1502.
Hurd, T.W., Fan, S., Liu, C.J., Kweon, H.K., Hakansson, K., and Marg-
olis, B. (2003). Phosphorylation-dependent binding of 14-3-3 to the
polarity protein Par3 regulates cell polarity in mammalian epithelia.
Curr. Biol. 13, 2082–2090.
Joberty, G., Petersen, C., Gao, L., and Macara, I.G. (2000). The cell-
polarity protein Par6 links Par3 and atypical protein kinase C to
Cdc42. Nat. Cell Biol. 2, 531–539.
Kamei, M., Saunders, W.B., Bayless, K.J., Dye, L., Davis, G.E., and
Weinstein, B.M. (2006). Endothelial tubes assemble from intracellular
vacuoles in vivo. Nature 442, 453–456.396 Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc.Kawakatsu, T., Shimizu, K., Honda, T., Fukuhara, T., Hoshino, T., and
Takai, Y. (2002). Trans-interactions of nectins induce formation of filo-
podia and Lamellipodia through the respective activation of Cdc42 and
Rac small G proteins. J. Biol. Chem. 277, 50749–50755.
Kazmierczak, B.I., Mostov, K., and Engel, J.N. (2004). Epithelial cell
polarity alters Rho-GTPase responses to Pseudomonas aeruginosa.
Mol. Biol. Cell 15, 411–419.
Kroschewski, R., Hall, A., and Mellman, I. (1999). Cdc42 controls se-
cretory and endocytic transport to the basolateral plasma membrane
of MDCK cells. Nat. Cell Biol. 1, 8–13.
Lacalle, R.A., Gomez-Mouton, C., Barber, D.F., Jimenez-Baranda, S.,
Mira, E., Martinez, A.C., Carrera, A.C., and Manes, S. (2004). PTEN
regulates motility but not directionality during leukocyte chemotaxis.
J. Cell Sci. 117, 6207–6215.
Ling, Q., Jacovina, A.T., Deora, A., Febbraio, M., Simantov, R., Silver-
stein, R.L., Hempstead, B., Mark, W.H., and Hajjar, K.A. (2004). An-
nexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J.
Clin. Invest. 113, 38–48.
Lubarsky, B., and Krasnow, M.A. (2003). Tube morphogenesis: making
and shaping biological tubes. Cell 112, 19–28.
Maehama, T., and Dixon, J.E. (1998). The tumor suppressor, PTEN/
MMAC1, dephosphorylates the lipid second messenger, phosphatidy-
linositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378.
Malacombe, M., Ceridono, M., Calco, V., Chasserot-Golaz, S.,
McPherson, P.S., Bader, M.F., and Gasman, S. (2006). Intersectin-
1L nucleotide exchange factor regulates secretory granule exocytosis
by activating Cdc42. EMBO J. 25, 3494–3503.
Meder, D., Shevchenko, A., Simons, K., and Fullekrug, J. (2005).
Gp135/podocalyxin and NHERF-2 participate in the formation of a pre-
apical domain during polarization of MDCK cells. J. Cell Biol. 168, 303–
313.
Merrifield, C.J., Rescher, U., Almers, W., Proust, J., Gerke, V., Sechi,
A.S., and Moss, S.E. (2001). Annexin 2 has an essential role in actin-
based macropinocytic rocketing. Curr. Biol. 11, 1136–1141.
Mertens, A.E., Rygiel, T.P., Olivo, C., van der Kammen, R., and Collard,
J.G. (2005). The Rac activator Tiam1 controls tight junction biogenesis
in keratinocytes through binding to and activation of the Par polarity
complex. J. Cell Biol. 170, 1029–1037.
Montesano, R., Schaller, G., and Orci, L. (1991). Induction of epithelial
tubular morphogenesis in vitro by fibroblast-derived soluble factors.
Cell 66, 697–711.
Munro, E.M. (2006). PAR proteins and the cytoskeleton: a marriage of
equals. Curr. Opin. Cell Biol. 18, 86–94.
Musch, A., Cohen, D., Kreitzer, G., and Rodriguez-Boulan, E. (2001).
cdc42 regulates the exit of apical and basolateral proteins from the
trans-Golgi network. EMBO J. 20, 2171–2179.
Nalbant, P., Hodgson, L., Kraynov, V., Toutchkine, A., and Hahn, K.M.
(2004). Activation of endogenous Cdc42 visualized in living cells. Sci-
ence 305, 1615–1619.
Nunbhakdi-Craig, V., Machleidt, T., Ogris, E., Bellotto, D., White, C.L.,
III, and Sontag, E. (2002). Protein phosphatase 2A associates with and
regulates atypical PKC and the epithelial tight junction complex. J. Cell
Biol. 158, 967–978.
O’Brien, L.E., Jou, T.S., Pollack, A.L., Zhang, Q., Hansen, S.H., Yurch-
enco, P., and Mostov, K.E. (2001). Rac1 orientates epithelial apical po-
larity through effects on basolateral laminin assembly. Nat. Cell Biol. 3,
831–838.
O’Brien, L.E., Zegers, M.M., and Mostov, K.E. (2002). Opinion: building
epithelial architecture: insights from three-dimensional culture models.
Nat. Rev. Mol. Cell Biol. 3, 531–537.
Puisieux, A., Ji, J., and Ozturk, M. (1996). Annexin II up-regulates cel-
lular levels of p11 protein by a post-translational mechanism. Biochem.
J. 313, 51–55.
Rescher, U., Ruhe, D., Ludwig, C., Zobiack, N., and Gerke, V. (2004).
Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein
recruited to actin assembly sites at cellular membranes. J. Cell Sci.
117, 3473–3480.
Schmid, A.C., Byrne, R.D., Vilar, R., and Woscholski, R. (2004). Bisper-
oxovanadium compounds are potent PTEN inhibitors. FEBS Lett. 566,
35–38.
Snyder, J.T., Rossman, K.L., Baumeister, M.A., Pruitt, W.M., Siderov-
ski, D.P., Der, C.J., Lemmon, M.A., and Sondek, J. (2001). Quantitative
analysis of the effect of phosphoinositide interactions on the function
of Dbl family proteins. J. Biol. Chem. 276, 45868–45875.
Suzuki, N., Buechner, M., Nishiwaki, K., Hall, D.H., Nakanishi, H., Ta-
kai, Y., Hisamoto, N., and Matsumoto, K. (2001). A putative GDP-
GTP exchange factor is required for development of the excretory
cell in Caenorhabditis elegans. EMBO Rep. 2, 530–535.
Vega-Salas, D.E., Salas, P.J., and Rodriguez-Boulan, E. (1987). Mod-
ulation of the expression of an apical plasma membrane protein of
Madin-Darby canine kidney epithelial cells: cell-cell interactions con-trol the appearance of a novel intracellular storage compartment. J.
Cell Biol. 104, 1249–1259.
von Stein, W., Ramrath, A., Grimm, A., Muller-Borg, M., and Wodarz,
A. (2005). Direct association of Bazooka/PAR-3 with the lipid phospha-
tase PTEN reveals a link between the PAR/aPKC complex and phos-
phoinositide signaling. Development 132, 1675–1686.
Weiner, O.D., Neilsen, P.O., Prestwich, G.D., Kirschner, M.W., Cantley,
L.C., and Bourne, H.R. (2002). A PtdInsP(3)- and Rho GTPase-medi-
ated positive feedback loop regulates neutrophil polarity. Nat. Cell
Biol. 4, 509–513.
Yu, W., O’Brien, L.E., Wang, F., Bourne, H., Mostov, K.E., and Zegers,
M.M. (2003). Hepatocyte growth factor switches orientation of polarity
and mode of movement during morphogenesis of multicellular epithe-
lial structures. Mol. Biol. Cell 14, 748–763.
Yu, W., Datta, A., Leroy, P., O’Brien, L.E., Mak, G., Jou, T.S., Matlin,
K.S., Mostov, K.E., and Zegers, M.M. (2005). Beta1-integrin orients ep-
ithelial polarity via Rac1 and laminin. Mol. Biol. Cell 16, 433–445.Cell 128, 383–397, January 26, 2007 ª2007 Elsevier Inc. 397
